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Abstract
Background—Apnea of prematurity (AOP) is nearly universal among very preterm infants, but 
neither the apnea burden nor its clinical associations have been systematically studied in a large 
consecutive cohort.
Methods—We analyzed continuous bedside monitor chest impedance and electrocardiographic 
waveforms and oxygen saturation data collected on all NICU patients <35 weeks gestation from 
2009–2014 (n=1211; >50 infant-years of data). “ABDs”, defined as central apnea ≥10 sec 
associated with both bradycardia <100 bpm and oxygen desaturation <80%, were identified using 
a validated automated algorithm.
Results—Number and duration of apnea events decreased with increasing gestational age (GA) 
and post-menstrual age (PMA). ABDs were more frequent in infants <31 wks GA at birth but 
were not more frequent in those with severe ROP, BPD or severe IVH after accounting for GA. In 
the day before diagnosis of late-onset septicemia and necrotizing enterocolitis, ABD events were 
increased in some infants. Many infants continued to experience short ABD events in the week 
prior to discharge home.
Conclusions—Frequency of apnea events is a function of GA and PMA in infants born preterm, 
and increased apnea is associated with acute but not with chronic pathologic conditions.
Introduction
Apnea of prematurity (AOP) reflects immaturity of brainstem and peripheral 
chemoreceptors and occurs in essentially all infants born at <28 weeks’ gestation and many 
of those born between 28–34 weeks.(1–4) AOP is commonly defined as cessation of 
breathing for >20 seconds, or >10 seconds with associated bradycardia or oxygen 
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desaturation.(5) In our research we use the abbreviation ABDn for episodes of central apnea 
of at least n seconds duration, when accompanied by both bradycardia and desaturation.(9) 
Hypoxia associated with apnea could have detrimental effects on developing tissues and 
organs resulting in long-term or permanent impairment (6–10), and therapies such as 
respiratory support and caffeine are only partially successful in reducing the burden of AOP. 
(11,12)Management of refractory apnea, optimum levels and durations of various therapies, 
and determining readiness for discharge from the Neonatal Intensive Care Unit (NICU) 
continue to be major challenges, and accurate quantitation of apnea is required for both 
clinical care and outcomes research. (13)
Quantitation of apnea in NICU patients has historically involved one of two approaches: 
medical record documentation of events by bedside caregivers, or short pneumographic 
recordings of respiratory impedance or inductance signals, heart rate, and oxygen saturation. 
These approaches are limited, the former by inaccuracy of reporting(14–16) and the latter by 
requirements for extra attachments to infants and time and expertise required for signal 
interpretation. As a result, previous studies of AOP are limited by small numbers of infants 
studied over short periods of time. Our group recently developed a novel automated 
computer algorithm for quantifying central apnea of prematurity from waveform and vital 
sign data continuously collected from standard NICU bedside monitors.(17) This system 
was clinically validated and allows identification of central AOP events in large numbers of 
infants for the entire NICU stay.
Clinical variables affecting the severity of AOP and the timing of resolution as infants 
approach term-corrected age are not well defined. Prior studies have shown an inverse 
correlation between gestational age at birth and postmenstrual age at which apnea resolves.
(18–20) Chronic or acute pathologic processes may also impact the occurrence, severity, and 
duration of AOP. For example, severe intraventricular hemorrhage (IVH) may be associated 
with central nervous system dysfunction that could manifest as central apnea(9,21,22), and 
bronchopulmonary dysplasia, with associated abnormal blood oxygen and carbon dioxide 
levels, may be associated with dysregulation of peripheral or central chemoreceptor 
sensitivity and increased apnea. Acute systemic inflammatory processes such as sepsis are 
known to lead to an abrupt increase in apnea over baseline in some infants.(23,24) It is also 
possible that hypoxemia association with AOP may contribute to pathology such as 
retinopathy of prematurity(7,10) or might contribute to neurodevelopmental 
impairment(6,10,25).
The goals of the current study were two-fold: to provide a comprehensive assessment of the 
burden of central apnea throughout the NICU stay of a large number of preterm infants, and 
to establish the association of AOP with chronic and acute pathologic processes.
Results
Demographics, clinical outcomes, and respiratory support
Of 1372 infants <35 weeks’ gestation admitted to the UVa NICU during the study period, 
chest impedance waveform and vital sign data were available for analysis for 1268. Figure 1 
shows the type of respiratory support for each infant relative to GA and PMA. Fifty-seven of 
Fairchild et al. Page 2
Pediatr Res. Author manuscript; available in PMC 2017 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
these infants were excluded from the ABD analysis because they had no chest impedance 
data off mechanical ventilation and prior to 40 weeks’ PMA, either due to death or transfer 
from our unit. Demographics and clinical outcomes of the 1211 infants with ABDs analyzed 
are shown in Table 1. Median gestational age for the entire cohort was 32 weeks (25th–
75th% 28–33 weeks). Birthweight distribution was 235 (19%) extremely low birth weight 
(<1000 grams) and 521 (43%) very low birth weight (<1500 grams).
Number of ABDs is inversely correlated with GA and PMA
ABD events were assessed when chest impedance, heart rate, and SpO2 data were available 
and infants were not on mechanical ventilation including nasal intermittent positive pressure 
ventilation (NIPPV). Median number of days analyzed per infant was 15 (25th–75th 
percentile 7–34 days, > 50 infant-years of data).
Figure 2 shows an example of an algorithm-detected ABD10 event, with the major features 
described in the caption (2A), and a histogram showing the number of infants in each GA 
week with at least one ABD10 event during the NICU stay (2B). Percentage of infants with 
at least one algorithm-detected ABD based on GA group is as follows: 97% of infants <27 
weeks, 92% of infants 27–30 weeks, 73% of infants 31–32 and 52% of infants 33–34 weeks.
Note that some infants with no detected ABDs may have been on prolonged mechanical 
ventilation or may have been transferred to our center at later PMAs for procedures.
Figure 3 includes two heat maps of the average daily number of ABD events for all 1211 
infants based on GA and PMA, with ABD10 and ABD20 shown (3A, 3B). Note that ABD20 
events (apnea at least 20 seconds with associated bradycardia <100 and desaturation <80% 
of any duration) are a subset of the ABD10 events. In these heat maps, warmer colors denote 
more apnea events each day, and are most evident in the lower left hand corners – lower GA 
and PMA. ABD10s persist to later PMAs compared to ABD20s – for example, the average 
number of ABD10s at 34 weeks PMA is 3 or more, while there is on average <1 ABD20 at 
34 weeks PMA. The inset of Figure 3A shows that the number of ABD10s at 32–36 weeks 
PMA is about 3-fold greater for infants <31 weeks GA compared to those 31–34 weeks. 
Among the infants <31 weeks GA, however, there is no significant impact of GA on the 
number of ABD10 at these later PMAs.
Lack of association of number of ABDs with severe ROP, BPD, and severe IVH 
(Supplemental Figure S1, online)
Since ROP has been linked to aberrant oxygenation(7,26,27), and since apnea is a major 
cause of hypoxia(28,29) and rebound hyperoxia(30), we tested the hypothesis that the 
number of ABD events would be greater in infants who developed severe ROP requiring 
laser or bevacizumab therapy. After accounting for GA, we did not find a statistically 
significant difference in the mean number of ABD10s throughout the NICU stay in 47 
infants with treated ROP compared to those without (Fig. S1A online). We also analyzed 
ABDs in infants with and without severe IVH (grade III-IV) and in those with BPD, since 
both of these conditions might be thought to lead to increased frequency of apnea. 
Considering all ABD10 events throughout the NICU stay, after accounting for GA there was 
no significant difference in number of apnea events in the 243 infants with BPD or the 51 
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infants with severe IVH (Fig S1B and S1C online) compared to infants without these 
morbidities. We further investigated whether, at later PMA when infants are maturing and 
nearing NICU discharge, infants with BPD or severe IVH have more central apnea spells 
with bradycardia and desaturation than those without. At 35 weeks’ PMA, we found that GA 
is significantly associated with BPD and severe IVH (ROC AUCs 0.927 and 0.817, 
respectively, p<0.0001), but that after accounting for GA infants with BPD did not have 
more ABD10s at 35 weeks PMA compared to babies without BPD, (ROC AUC 0.927, 
change in AUC 0, p=0.63). For babies with severe IVH there was a trend toward more ABDs 
at 35 weeks PMA that was not statistically significant (ROC AUC 0.832, change in AUC 
0.015, p=0.085).
Apnea increases before diagnosis of late-onset septicemia and NEC (Supplemental Figure 
S2 online)
Acute systemic inflammatory processes can be associated with apnea in preterm infants(23), 
and we therefore analyzed ABDs in these illnesses. We identified 28 cases of LOS and 21 
cases of NEC in infants when they were not on mechanical ventilation and had chest 
impedance and vital sign data available for analysis >50% of the time in the 48 hour period 
prior to diagnosis. In seven cases of NEC (33%) and 12 cases of LOS (43%) infants had at 
least 2-fold increased ABD events in the 24h period prior compared to 24–48h prior to 
diagnosis. We also analyzed number of seconds of apnea associated with bradycardia and 
desaturation in the 24h period before diagnosis compared to 24–48h prior, and found similar 
results as shown in Figure S2 online.
ABD events in the week prior to discharge home from the NICU
We sought to determine whether infants continued to experience mild, self-resolved or not 
clinically recognized ABD events in the week prior to NICU discharge. Of the 1211 infants 
included in this analysis, 1048 were discharged home (the others either died or were 
transferred to another unit). Decisions about readiness for discharge were made by the 
clinical care team without knowledge of algorithm-detected ABDs. Caffeine was usually 
discontinued between 32–34 weeks’ PMA, when the infant was off CPAP and no longer 
having significant clinically detected apnea events requiring stimulation. In our unit during 
the period of this study, there was a general policy of an 8-day “apnea countdown” with no 
events requiring intervention before discharge home.(18) Minor apnea events that are self-
resolved or that occur during feeding generally do not delay discharge, and events that occur 
following immunizations or general anesthesia near the time of NICU discharge do not 
restart the apnea countdown. Cardiorespiratory monitors are routinely prescribed for infants 
going home on supplemental oxygen and are occasionally prescribed for other infants with 
clinical conditions or events at the discretion of the medical team.
PMA for the 1048 infants discharged home was 36.6 +/− 2.7 weeks. In the seven days prior 
to discharge, no ABD10s were detected by the automated algorithm in 508 infants (48%), 
whereas 146 infants (14%) had 10 or more events (Table 2). GA was significantly lower in 
infants with ABDs in the week before discharge, but PMA at discharge was similar for 
infants with and without discharge week ABDs. A home apnea monitor or pulse oximeter or 
both were prescribed at discharge for 168 infants (16%), including all infants discharged on 
Fairchild et al. Page 4
Pediatr Res. Author manuscript; available in PMC 2017 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
supplemental oxygen and 58 infants discharged on room air. Fourteen infants not on 
supplemental oxygen and with no ABDs detected by our algorithm in the week prior to 
discharge were sent home with a monitor, while 103 babies with more than 10 ABDs 
detected in the week prior to discharge were sent home without a monitor.
ALTE and SIDS
As shown in Table 2, fifteen infants were readmitted within 8 weeks of NICU discharge for 
apnea or apparent life-threatening event (ALTE), including 2% of infants with one or more 
discharge week ABDs and 0.8% of infants with no discharge week ABDs (p=0.17).
Reviewing matched birth/death records from the state of Virginia, we found one SIDS death 
in the study population. The infant was a 32 week GA twin discharged at 35 weeks PMA 
who died two weeks after NICU discharge with a forensic autopsy identifying cause of death 
as SIDS. As we previously reported, during her 3 weeks in the NICU, she had excessive 
periodic breathing – five-fold more than other 32 week infants – but no clinically recorded 
apnea and only one computer-detected ABD10 event, which did not occur in the week prior 
to discharge.(31)
Discussion
We provide a quantitative analysis of central apnea throughout the NICU stay of 1211 
preterm infants that confirms some old concepts about AOP and challenges others. We 
found, as expected, that apnea accompanied by both bradycardia and oxygen desaturation is 
common in the NICU despite respiratory and pharmacologic treatments administered to 
nearly all very preterm infants. We confirmed that an acute increase in ABD events may 
occur in the day prior to diagnosis of an acute illness such as sepsis or NEC. On the other 
hand, chronic pathologic processes (ROP, BPD, IVH) were not significantly associated with 
the frequency of central apnea after controlling for gestational age. Finally, we found that 
longer apneas (ABD20s) resolve earlier than shorter ones, and ABD10 events are not 
uncommon in the week prior to NICU discharge of healthy preterm infants.
Limitations of the automated apnea detection system
Our apnea detection algorithm requires low or absent variance in the chest impedance signal 
to detect cessation of breathing efforts, and thus detects only central apnea. Preterm infants 
also have obstructive apnea, which may or may not be accompanied by some degree of 
motion of the chest wall and abdomen. The algorithm filters out gross motion artifact before 
identifying breathing signals in the impedance waveform, but it was not designed to identify 
obstructive apnea. Prior studies using measures of nasal airflow (thermistors or carbon 
dioxide detectors) and respiratory inductance plethysmography indicate that the majority of 
apnea events in preterm infants have both central and obstructive components. Our 
methodology will miss pure obstructive events but will capture pure central and most mixed 
central/obstructive events.
We employed a stringent definition of apnea, requiring both bradycardia and oxygen 
desaturation, in order to measure the most clinically significant events. Many other studies, 
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and the NICHD Consensus Statement(5), define AOP as cessation of breathing with 
bradycardia or desaturation and give slightly different thresholds for “BD”. Also, the 
algorithm detects ABD events irrespective of whether they are noticed or are considered 
clinically important. We previously reported that medical record documentation does not 
accurately reflect occurrence of ABD events,(32) and speculate that many of the algorithm-
detected events are self-resolved or are occurring during or following procedures, handling, 
or feeding and therefore not necessarily documented by bedside caregivers.
Finally, we are reporting only on the number of ABD events, thus we do not make any 
statements about depth or duration of bradycardia or oxygen desaturation.
Apnea prior to diagnosis of acute illness
An acute increase in apnea is generally thought to reflect acute stress or illness in preterm 
infants, and our study provides quantitative evidence of this. Apnea during septicemia or 
necrotizing enterocolitis is likely attributable at least in part to release of prostaglandins 
during a systemic inflammatory response (33–35). Many infants did not experience an 
increase in apnea during sepsis or NEC and we do not have enough cases to determine 
whether apnea is more likely to occur with specific organisms or reflects a higher severity of 
illness. Future work will focus on whether real-time analysis and display of abnormal 
respiratory or other vital sign patterns could provide early warning of potentially 
catastrophic illnesses, leading to earlier treatment and improved outcomes.
Lack of association of apnea frequency and chronic morbidities
After accounting for gestational age, we did not find a greater number of ABD events among 
infants with severe ROP. Large randomized clinical trials have demonstrated that targeting 
lower SpO2 results in lower rates of ROP (27) but a smaller retrospective study suggested 
that intermittent hypoxia events are linked to more severe ROP.(7) It is likely that retinal 
vascular pathology is related to both hyperoxia and hypoxia and to the phase of development 
at which aberrant SpO2 occurs. We did not analyze the timing, depth or duration of hypoxia 
during apneic events, nor did we assess hypoxia occurring without central apnea(36). Most 
of our infants with severe ROP were ≤25 weeks GA and were on prolonged mechanical 
ventilation, which precludes apnea but does not preclude dysoxia that might contribute to 
ROP.
The finding that infants with BPD did not have more central apnea was surprising, since 
chemoreceptor dysregulation might be expected in these infants(3). It is possible that infants 
with significant lung disease are on mechanical ventilation or other respiratory support and 
caffeine for prolonged periods of time when they are most susceptible, and thus apnea is 
masked. Infants with BPD may also be more prone to obstructive apnea(28,37,38) which we 
did not measure. Other studies reviewing apnea or bradycardia events documented in the 
medical record have reported more events in very preterm infants with BPD.(19,20)
We did not find a significant difference in number of ABDs in infants with severe IVH 
though there was a trend toward slightly more ABDs at later PMA. The number of infants 
with high-grade IVH in our cohort was small, and we did not separately analyze the even 
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smaller fraction of infants with post-hemorrhagic hydrocephalus who might have more 
apnea. Additionally, our methods did not allow us to assess whether infants with IVH had 
more obstructive apnea as has been reported by others.(21) Larger studies would be required 
to determine whether, as has been reported in a small study, pre-discharge apnea predicts 
adverse neurodevelopment at several years of age in preterm infants with severe IVH.(8)
Resolution of apnea
We found, consistent with other reports, (18–20,23) that infants born at gestations <31 
weeks had apnea to later PMA than those born less preterm. This reaffirms that a specific 
PMA (e.g. 36 weeks) cannot be used as a “safe” benchmark for low apnea risk without also 
considering GA. In the spectrum from 23–31 weeks’ GA, however, our data show that the 
number of ABD events by the time infants reached 35 weeks PMA was no longer a function 
of GA at birth. This is in contrast to findings of other studies(19,20) that relied on medical 
record documentation of events and therefore probably captured more events that required 
intervention and were considered clinically important. These studies also included 
bradycardia or apnea episodes and thus likely included obstructive apnea and vagal 
bradycardia which we did not measure.
Many infants in our cohort who were otherwise ready for discharge home continued to have 
short algorithm-detected ABDs. These events may have been self-resolved or occurred 
during feeding or stressors such as immunization, (39) Most infants were sent home without 
a monitor and very few were readmitted to our hospital within 2 months for apnea or ALTE, 
which is in keeping with other reports.(40) Our unit protocol of discharging infants after a 
week free of needing stimulation to resolve an apneic spell has not changed based on our 
studies to date, and further work in larger patient populations is needed to establish criteria 
for safe NICU discharge, since the cost of additional hospital days simply for an “apnea 
countdown” is substantial.(41)
Conclusion
Apnea events with associated bradycardia and oxygen desaturation occur frequently in 
hospitalized preterm neonates in spite of respiratory support and caffeine. Further research is 
needed to determine the long-term impact of these events and identify therapies to minimize 
apnea burden in the NICU.
Methods
Study Population and Data Collection
We stored and analyzed the bedside monitor waveforms and vital signs of all infants <35 
weeks’ gestation in the University of Virginia NICU from January 2009 through March 
2014. The study was approved by the UVA Institutional Review Board as requiring no 
consent, since all data were analyzed retrospectively and could not influence patient care.
Demographic and clinical data, including dates on and off mechanical ventilation and other 
respiratory support, were obtained from the electronic medical record. Clinical decisions 
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were made by the care team without knowledge of computer algorithm-detected apneas. 
Caffeine was given based on our unit policy of initiating caffeine for all infants <32 weeks 
GA at birth, and discontinuing caffeine after 32 weeks postmenstrual age once the infant was 
off continuous positive airway pressure and having little or no clinically recognized apnea 
requiring stimulation. Decisions about dosing and duration of caffeine and readiness for 
discharge home were based on standard assessment of bedside monitor data, medical record 
documentation, and nursing reports of apnea events. Generally in our unit during the years 
of this study, an 8-day period free of apnea requiring stimulation was required prior to 
discharge.(18)
Clinical events and conditions were recorded in a relational clinical database. Severe 
intraventricular hemorrhage (IVH) grade III-IV was identified by serial head ultrasounds. 
Bronchopulmonary dysplasia (BPD) was defined as requirement for supplemental oxygen in 
our NICU at 36 weeks postmenstrual age. Infants who were transferred to an outside 
hospital on oxygen prior to 36 weeks’ PMA and for whom the subsequent oxygen status was 
not known were not included in the BPD analysis. Late-onset septicemia (LOS) was defined 
as signs of sepsis >3 days from birth, positive blood culture, and antibiotic treatment for at 
least 5 days. Diagnosis of necrotizing enterocolitis required abdominal signs with abdominal 
radiograph showing pneumatosis, portal venous air, or pneumoperitoneum, or requirement 
for surgery. Cases of NEC with associated septicemia were classified as NEC alone. Severe 
retinopathy of prematurity (ROP) was defined as requiring laser photoablation or 
intravitreous bevacizumab therapy.
Data Analysis
Development and validation of the apnea detection system used in this study were 
previously reported(17). Bedside monitor data were collected using a central network server 
(BedMaster Ex, Excel Medical, Jupiter, FL), including chest impedance waveforms (60 Hz), 
electrocardiogram waveforms (3 leads at 240 Hz each), and every 2 second oxygen 
saturation from pulse oximetry signals (using 8 second SpO2 averaging). A computer 
algorithm was developed to detect episodes of low variance in the chest impedance 
waveform signal after eliminating heart beat and motion artifact. Temporally associated 
declines in heart rate to less than 100 bpm and in oxygen saturation to less than 80% were 
identified. The algorithm identified ABDn events as central apnea of at least n seconds with 
both bradycardia and desaturation of any duration. For example, ABD10 denotes an episode 
of cessation of chest movement of 10 or more seconds with associated bradycardia <100 
bpm of any duration and desaturation <80% of any duration. The algorithm underwent 
extensive development, testing, and validation(17).
Statistical Analysis
Continuous variables were analyzed by t-test or ANOVA and categorical variables by 
Fischer exact test. Receiver operator characteristics curves were constructed, and change in 
ROC area was analyzed to determine the impact of GA, severe IVH, and BPD on number of 
ABD events at 35 weeks PMA. Number of ABDs in the day prior to septicemia or NEC 
diagnosis was compared to the prior 1-day baseline for each infant by sign rank test. 
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Statistical significance was considered as two-tailed p<0.05, and analyses were conducted in 
MATLAB (MathWorks, Natick, MA)
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Respiratory support
Type of respiratory support over the course of the NICU stay is shown for all 1268 infants 
<35 weeks’ GA with bedside monitor data available for analysis. Number of infants in each 
GA week group is shown on the right y axis, and the change in color represents mode of 
respiratory support with advancing postmenstrual age: ventilator (black), nasal continuous 
positive airway pressure (CPAP, green), nasal cannula (NC, yellow), and room air (blue).
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Figure 2. Apnea, bradycardia, desaturation example and incidence
Apnea at least 10 seconds with associated bradycardia <100 beats/minute and oxygen 
desaturation <80% were analyzed using a published algorithm(17) A) Graphic 
representation of 60 seconds of vital sign and waveform data showing a representative ABD 
event. From top to bottom: Heart rate (HR with 100 beats per minute threshold of 
bradycardia indicated by the thin green line), oxygen saturation (SpO2 with 80% threshold 
of desaturation indicated by the thin blue line), chest impedance (CI), filtered chest 
impedance (FCI), and computer algorithm-detected probability of apnea (PA). An “ABD10” 
event is shown, with apnea duration >10 seconds and associated bradycardia and oxygen 
desaturation. Another shorter breathing pause occurred without associated bradycardia, 
which did not meet our definition of an “ABD” event. B) ABDs were analyzed on all infants 
all times that bedside monitor data were available and the infant was not on mechanical 
ventilation. Number of infants of each gestational age with at least one algorithm-detected 
ABD10 event (black fill) and with no events detected (white) is shown.
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Figure 3. Mean number of ABD events per day based on gestational and postmenstrual age
For 1211 infants <35 weeks’ GA, ABDs were analyzed during all times that data were 
available and infants were not on mechanical ventilation. A) Heat map of mean daily 
#ABD10s (apnea at least 10 seconds with associated bradycardia and desaturation) for each 
week of GA and PMA. Color scale goes from blue (zero) to red (eight) events per day. The 
line graph below showsmean daily #ABD10s for infants <27 weeks GA (blue), 27–30 weeks 
(green), and 31–34 weeks (red).
B) Mean daily #ABD20s (apnea at least 20 seconds with bradycardia and desaturation) for 
each week of GA and PMA.
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Table 1
Characteristics and outcomes of 1211 infants with ABDs analyzed
<27 wk (n= 190) 27–30 wk (n=297) 31–34 wks (n=724)
Gestational age weeks 25 (24–26) 29 (28–30) 33 (32–34)
Birth weight grams 750 (640–850) 1200 (1020–1440) 1950 (1670–2270)
Death before NICU discharge 7 (3.7%) 5 (1.7%) 7 (1.0%)
Severe IVH (Grade III–IV) 34 (16%) 10 (3.4%) 3 (0.4%)
Late-onset septicemia 62 (29%) 24 (8.1%) 9 (1.2%)
Necrotizing enterocolitis 16 (7%) 16 (5.4%) 9 (1.2%)
Bronchopulmonary dysplasia* 119/175 (68%) 72/283 (25%) 26/719 (3.6%)
Treated retinopathy of prematurity** 42 (22%) 4 (1.3%) 0
Discharged home 145 (68%) 244 (77%) 650 (88%)
Postmenstrual age at d/c home 39 (37–41) 36 (35–38) 35.5 (35–36)
Data presented as median (25th–75th%ile) or n (%)
*denominator is number for whom outcome at 36 weeks PMA is known
**
Laser or bevacizumab
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Table 2
ABD10s in the week before discharge home
No ABDs (n=508) 1–10 ABDs (n=394) >10 ABDs (n=146) p = *
Gestational age weeks 33 (31–34) 31 (28–31) 30 (27–31) <0.001
Discharge PMA weeks 36 (35–37) 36 (35–38) 36 (35–38) 0.45
No monitor** at discharge 460 (91%) 319 (81%) 103 (71%) <0.001
Oxygen and monitor at discharge 34 (6.7%) 51 (13%) 24 (16%) <0.001
Monitor, no oxygen at discharge 14 (2.8%) 24 (6.1%) 19 (13%) <0.001
Readmitted for apnea or ALTE† 4 (0.8%) 7 (1.8%) 4 (2.7%) 0.71
Median (25th–75th%) or n (%)
*
≥1 ABD versus no ABD
**Apnea monitor or pulse oximeter
†Admitted to UVa Hospital within 8 weeks of UVa NICU discharge
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